Identifying drug targets one protein at a time
November 26, 2013, 5:52 pm
The Open Access nature of SGC work is discussed in this article on CreativeCommons.org
LLY-507: A chemical probe for SMYD2 protein lysine methyltransferase
November 12, 2013, 10:36 am
A collaboration between the SGC and Eli Lilly and Company has resulted in the discovery of LLY-507, a chemical probe for SMYD2 (a protein lysine methyltransferase).
PFI-3: Selective chemical probe for SMARCA domains
November 1, 2013, 9:29 am
The SGC has developed an inhibitor, PFI-3, against the SMARCA2/4 and PB1(5) bromodomains
SGC Announces Janssen has joined Public-Private Drug Discovery Partnership
October 27, 2013, 10:54 am
The Structural Genomics Consortium (SGC) announced today that Janssen Pharmaceuticals NV has joined its group to partner in the investigation of epigenetics-based drug research, a new and... [read more]
Putting drug discovery back on target
October 27, 2013, 9:04 am
The SGC's Prof. Chas Bountra interviewed for the University of Oxford website. [article].